Jump to content

User:Qwr2../Sample page

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
RO-5256390
Identifiers
  • (S)-4-((S)-2-phenyl-butyl)-4,5-dihydro-oxazol-2-ylamine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC13H18N2O
Molar mass218.300 g·mol−1
3D model (JSmol)
  • NC1=N[C@@H](C[C@@H](C2=CC=CC=C2)CC)CO1
  • InChI=1S/C13H18N2O/c1-2-10(11-6-4-3-5-7-11)8-12-9-16-13(14)15-12/h3-7,10,12H,2,8-9H2,1H3,(H2,14,15)/t10-,12-/m0/s1
  • Key:IXDKFUBXESWHSL-JQWIXIFHSA-N

RO-5256390 is a drug developed by Hoffmann-La Roche which acts as an agonist for the trace amine associated receptor 1. It is shown to block compulsive and binge-like eating behavior in rats.[1]

Reference section

  1. ^ Ferragud, Antonio; Howell, Adam D.; Moore, Catherine F.; Ta, Tina L.; Hoener, Marius C.; Sabino, Valentina; Cottone, Pietro (2017-06). "The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats". Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 42 (7): 1458–1470. doi:10.1038/npp.2016.233. ISSN 1740-634X. PMC 5436108. PMID 27711047. {{cite journal}}: Check date values in: |date= (help)